ABSTRACT
SUMMARY: Leptin is a 16 kilodaltons hormone secreted by adipose tissue and in the past few years it has been related to the reproductive system regulation. Leptin and its receptor (OBR) have been described in several reproductive organs and in different species but, in epididymis, there is still a lack of information. The aim of this work is to establish if leptin and its receptor are present on epididymis and where the production is occurring. At mRNA level the cauda portion showed a high expression of leptin (p<0.025) and OBRa (p<0.002) while at protein level the OBR expression was lower in cauda region (p<0.025) and leptin was not detected. The ratio between OBRa and OBRb was higher in both regions despite its total amount. By immunohistochemistry leptin and OBR were detected on epididymis epithelia, restricted to clear cells (CC). After efferent duct ligation (EDL) a decrease on leptin staining on CC was observed, suggesting that despite of epididymis production, most of leptin source may probably come from testis. Our results show that leptin and OBR, both mRNA and protein, are present on epididymis and exclusively in CC, suggesting that this tissue is responsive to the hormone and may have an important role on CC regulation.
RESUMEN: La leptina es una hormona de 16 kilodaltons secretada por el tejido adiposo y se ha relacionado en los últimos años con la regulación del sistema reproductivo. La leptina y su receptor (OBR) se han reportado en varios órganos reproductores y en diferentes especies sin embargo, en el epidídimo aún falta información. El objetivo de este trabajo fue establecer si la leptina y su receptor están presentes en el epidídimo y donde se produce. A nivel de ARNm la porción de cauda mostró una alta expresión de leptina (p <0,025) y OBRa (p <0,002) mientras que a nivel de proteína la expresión de OBR fue menor en la región de la cauda epididimaria (p <0,025) y no se detectó leptina. La relación entre OBRa y OBRb fue mayor en ambas regiones a pesar de su cantidad total. Por inmunohistoquímica se detectaron leptina y OBR en el epitelio del epidídimo restringido a células claras (CC). Después de la ligadura del conducto deferente (EDL) se observó una disminución en la tinción de leptina en CC, lo que sugiere que a pesar de la producción del epidídimo, la mayor parte de la fuente de leptina puede provenir probablemente del testículo. Nuestros resultados mostraron que la leptina y OBR, mRNA y proteína, están presentes en el epidídimo y exclusivamente en CC, lo que sugiere que este tejido es sensible a la hormona y puede tener un papel importante en la regulación CC.
Subject(s)
Animals , Male , Rats , Leptin/metabolism , Epididymis/metabolism , Receptors, Leptin/metabolism , Immunohistochemistry , Blotting, Western , Rats, Wistar , Real-Time Polymerase Chain ReactionABSTRACT
PURPOSE: The aim of this study was to evaluate the expression of leptin and its receptor in histological sections of prostate tumors, and their association with prognostic factors. METHODS: A total of 532 surgical specimens from prostate cancer were studied. After histopathological diagnosis, the samples were included in tissue microarrays containing cores from tumor and non-tumor (benign prostatic hyperplasia) areas. These were immunostained with anti-leptin and anti-leptin-receptor antibodies. Objective and subjective analyses were performed. Student's-t-test and ANOVA were used to compare mean values, and linear regression was used to evaluate the correlation between histological results and prognostic indicators. RESULTS: Leptin receptor expression was reduced in tumors with a positive surgical margin, urethral margin involvement, and seminal vesicles invasion. Further, there was a negative correlation between the expression of leptin receptor in tumor areas and the sum of prognostic factors, suggesting that leptin receptor may predict the aggressiveness of disease. CONCLUSION: Our findings suggest that leptin receptor expression is a potential prognostic factor for PCa. Further investigation is needed to support the use of leptin receptor as a novel biomarker, although leptin itself does not seem to predict the aggressiveness of prostate cancer. .